Tricuspid Regurgitation Clinical Trial
Official title:
Dawneo Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System Pivotal Clinical Trial (NoTR): A Trial to Evaluate the Safety and Effectiveness of Transcatheter Valve Edge-to-edge Repair System in Patients With Severe Tricuspid Regurgitation
To evaluate the safety and effectiveness of Dawneo Neoblazar® transcatheter tricuspid valve edge-to-edge repair system in patients with severe tricuspid regurgitation. This is a prospective, multicenter, randomized, objective performance criteria trial. 98 patients who meet the inclusion criteria will be included in the study. This study will be conducted in in each site as run-in subjects. Subjects who meet the requirements and who voluntarily participate in the trial and sign the informed consent form, will be implanted with the Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System.
OBJECTIVES:To evaluate the safety and effectiveness of Dawneo Neoblazar® transcatheter tricuspid valve edge-to-edge repair system in patients with severe tricuspid regurgitation. CLINICAL INVESTIGATION POPULATION:Patients who are on echocardiographic evidence of severe tricuspid regurgitation. CLINICAL INVESTIGATION DESIGN:This is a prospective, multicenter, single arm, objective performance criteria trial. 98 patients who meet the inclusion criteria will be included in the study. This study will be conducted in in each site as run-in subjects. Subjects who meet the requirements and who voluntarily participate in the trial and sign the informed consent form, will be implanted with the Neoblazar® Transcatheter Tricuspid Valve Edge-to Edge Repair System. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05434507 -
Feasibility Study of Treating Tricuspid Regurgitation With K-ClipTM Transcatheter Annuloplasty System
|
N/A | |
Completed |
NCT03144024 -
Comparison of Rigid Annuloplasty Ring With a Band in the Correction of Secondary Tricuspid Insufficiency
|
N/A | |
Enrolling by invitation |
NCT05825898 -
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
|
||
Completed |
NCT05836493 -
Very Long-term (>15 Years) Results of Tricuspid Valve Repair.
|
||
Enrolling by invitation |
NCT06033274 -
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
|
||
Recruiting |
NCT05671640 -
Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation
|
N/A | |
Recruiting |
NCT06027307 -
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
|
Phase 3 | |
Terminated |
NCT04665583 -
Prehab Prior to Undergoing Tricuspid Intervention
|
||
Recruiting |
NCT06307262 -
European Registry of Transcatheter Repair for Tricuspid Regurgitation
|
||
Completed |
NCT02981953 -
TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System
|
N/A | |
Recruiting |
NCT04433065 -
TTVR Early Feasibility Study
|
N/A | |
Not yet recruiting |
NCT05556460 -
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
|
N/A | |
Recruiting |
NCT05667519 -
Prevention of Pacemaker Lead Induced Tricuspid regurgitAtion by Transesophageal eCho guidEd Implantation (PLACE)
|
N/A | |
Recruiting |
NCT04653428 -
German Registry for Transcatheter Tricuspid Valve Interventions
|
||
Recruiting |
NCT05179616 -
Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair
|
||
Completed |
NCT02644616 -
The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
|
Phase 4 | |
Recruiting |
NCT05328284 -
PASCAL for Tricuspid Regurgitation - a European Registry
|
||
Completed |
NCT02675244 -
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
|
N/A | |
Recruiting |
NCT05436028 -
A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
|
N/A | |
Completed |
NCT01093001 -
Tricuspid Regurgitation Study
|
Phase 4 |